연구성과로 돌아가기
JCR 2022 저널 목록 (1360 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Advances in Mental Health and Intellectual Disabilities | EMERALD GROUP PUBLISHING LTD | 2044-1282 | 2044-1290 | ESCI | PSYCHIATRY | 303 | 1.1 | N/A | 100.0 | N/A | N/A | 1.1 | N/A | 0.9 | 0.1 | 0.26 | 220/264 | Q4 | 16.86 | 0.000 | 0.058 | 0.263 | Q2 | 20 | 80.0% | 6.6 | 8.7 | 16 | 4.6% | 2025-04-21 10:28:31 | 바로가기 |
| Advances in Multimedia | HINDAWI LTD | 1687-5680 | 1687-5699 | ESCI | ENGINEERING, ELECTRICAL & ELECTRONIC | 318 | 1.4 | N/A | 100.0 | N/A | N/A | 1.6 | N/A | 1.3 | 0.2 | 0.22 | 295/352 | Q4 | 16.34 | 0.000 | 0.043 | 0.199 | Q3 | 350 | 99.7% | 4.3 | 3.2 | 349 | 99.5% | 2025-04-21 09:52:28 | 바로가기 |
| Advances in Natural Sciences-Nanoscience and Nanotechnology | IOP Publishing Ltd | 2043-6254 | 2043-6262 | ESCI | MATERIALS SCIENCE, MULTIDISCIPLINARY | 2,467 | 2.1 | N/A | 100.0 | N/A | N/A | N/A | N/A | 2.0 | 0.3 | 0.33 | 313/424 | Q3 | 26.30 | 0.001 | 0.245 | N/A | N/A | 68 | 86.8% | 6.3 | 5.9 | 59 | 0.0% | 2025-04-21 10:11:18 | 바로가기 |
| Advances in Natural Sciences-Nanoscience and Nanotechnology | IOP Publishing Ltd | 2043-6254 | 2043-6262 | ESCI | NANOSCIENCE & NANOTECHNOLOGY | 2,467 | 2.1 | N/A | 100.0 | N/A | N/A | N/A | N/A | 2.0 | 0.3 | 0.33 | 105/141 | Q3 | 25.89 | 0.001 | 0.245 | N/A | N/A | 68 | 86.8% | 6.3 | 5.9 | 59 | 0.0% | 2025-04-21 10:18:16 | 바로가기 |
| Advances in Natural Sciences-Nanoscience and Nanotechnology | IOP Publishing Ltd | 2043-6254 | 2043-6262 | ESCI | PHYSICS, APPLIED | 2,467 | 2.1 | N/A | 100.0 | N/A | N/A | N/A | N/A | 2.0 | 0.3 | 0.33 | 133/178 | Q3 | 25.56 | 0.001 | 0.245 | N/A | N/A | 68 | 86.8% | 6.3 | 5.9 | 59 | 0.0% | 2025-04-21 10:25:27 | 바로가기 |
| Advances in Neurodevelopmental Disorders | SPRINGERNATURE | 2366-7532 | 2366-7540 | ESCI | EDUCATION, SPECIAL | 293 | 1.1 | N/A | 100.0 | N/A | N/A | N/A | N/A | 1.0 | 0.5 | 0.52 | 51/62 | Q4 | 18.55 | 0.001 | 0.120 | N/A | N/A | 75 | 82.7% | 3.2 | 7.8 | 62 | 21.4% | 2025-04-21 09:49:39 | 바로가기 |
| Advances in Neurodevelopmental Disorders | SPRINGERNATURE | 2366-7532 | 2366-7540 | ESCI | PSYCHOLOGY, DEVELOPMENTAL | 293 | 1.1 | N/A | 100.0 | N/A | N/A | N/A | N/A | 1.0 | 0.5 | 0.52 | 75/92 | Q4 | 19.02 | 0.001 | 0.120 | N/A | N/A | 75 | 82.7% | 3.2 | 7.8 | 62 | 21.4% | 2025-04-21 10:30:01 | 바로가기 |
| Advances in Neurodevelopmental Disorders | SPRINGERNATURE | 2366-7532 | 2366-7540 | ESCI | REHABILITATION | 293 | 1.1 | N/A | 100.0 | N/A | N/A | N/A | N/A | 1.0 | 0.5 | 0.52 | 124/169 | Q3 | 26.92 | 0.001 | 0.120 | N/A | N/A | 75 | 82.7% | 3.2 | 7.8 | 62 | 21.4% | 2025-04-21 10:33:35 | 바로가기 |
| Advances in Operations Research | HINDAWI LTD | 1687-9147 | 1687-9155 | ESCI | OPERATIONS RESEARCH & MANAGEMENT SCIENCE | 195 | 1.2 | N/A | 100.0 | N/A | N/A | 2.1 | N/A | 1.2 | 0.3 | 0.18 | 98/104 | Q4 | 6.25 | 0.000 | 0.035 | 0.411 | Q3 | 12 | 91.7% | 6.0 | 6.1 | 11 | 100.0% | 2025-04-21 10:21:35 | 바로가기 |
| Advances in Operator Theory | SPRINGER BASEL AG | 2662-2009 | 2538-225X | ESCI | MATHEMATICS | 250 | 0.8 | N/A | 100.0 | N/A | N/A | 0.7 | N/A | 0.8 | 0.2 | 0.77 | 169/485 | Q2 | 65.26 | 0.001 | 0.200 | 0.340 | Q1 | 61 | 100.0% | 2.7 | 15.6 | 61 | 8.0% | 2025-04-21 10:13:41 | 바로가기 |
| Advances in Orthopedics | HINDAWI LTD | 2090-3464 | N/A | ESCI | ORTHOPEDICS | 537 | 1.3 | N/A | 100.0 | N/A | N/A | 1.7 | N/A | 1.3 | 0.3 | 0.61 | 76/130 | Q3 | 41.92 | 0.001 | 0.120 | 0.467 | Q2 | 38 | 81.6% | 6.8 | 8.2 | 31 | 100.0% | 2025-04-21 10:22:24 | 바로가기 |
| Advances in Pharmacological and Pharmaceutical Sciences | HINDAWI LTD | 2633-4682 | 2633-4690 | ESCI | PHARMACOLOGY & PHARMACY | 217 | 2.8 | N/A | 100.0 | N/A | N/A | 2.8 | N/A | 2.7 | 0.5 | 0.54 | 221/366 | Q3 | 39.75 | 0.000 | 0.045 | 0.349 | Q2 | 48 | 83.3% | 2.0 | 7.0 | 40 | 100.0% | 2025-04-21 10:24:01 | 바로가기 |
| Advances in Pharmacology and Pharmacy | HORIZON RESEARCH PUBLISHING | 2332-0036 | 2332-0044 | ESCI | PHARMACOLOGY & PHARMACY | 41 | 0.1 | N/A | 100.0 | N/A | N/A | 0.3 | N/A | 0.1 | 0.1 | 0.06 | 357/366 | Q4 | 2.60 | 0.000 | 0.003 | 0.029 | Q4 | 31 | 83.9% | N/A | 11.0 | 26 | 98.3% | 2025-04-21 10:24:03 | 바로가기 |
| Advances in Public Health | HINDAWI LTD | 2356-6868 | 2314-7784 | ESCI | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 448 | 4.1 | N/A | 100.0 | N/A | N/A | N/A | N/A | 4.1 | 0.3 | 0.77 | 155/400 | Q2 | 61.38 | 0.001 | 0.139 | N/A | N/A | 31 | 100.0% | 3.3 | 6.4 | 31 | 97.5% | 2025-04-21 10:31:53 | 바로가기 |
| Advances in Pure and Applied Mathematics | ISTE GROUP | 1867-1152 | 1869-6090 | ESCI | MATHEMATICS | 107 | 0.4 | N/A | 100.0 | N/A | N/A | 0.5 | N/A | 0.4 | <0.1 | 0.51 | 310/485 | Q3 | 36.19 | 0.000 | 0.052 | 0.257 | Q2 | 16 | 100.0% | 5.8 | 21.3 | 16 | 0.0% | 2025-04-21 10:13:49 | 바로가기 |
페이지 이동: